RGT 2.80% 55.0¢ argent biopharma limited

Cannepil, page-39

  1. 6,434 Posts.
    lightbulb Created with Sketch. 5274

    Just sharing what I read & thoughts.  This ANN is pretty important & considering we only got GMP Certification in July:

    https://www.asx.com.au/asxpdf/20180731/pdf/43wxgzj94cgjf9.pdf

    Red like many others, but I guess that is up to each individual how long they are willing to hold on, what will happen for Pharma arm etc with Cannaglobal.  

    I’m hoping we see something with Cannepil soon & the interesting thing is that it took Tilray from March until September 2018 to ANN shipment of treatment drugs.  It appears that it is no easy or fast process for any company in the early stages of investigational drugs, but that certainly does not mean they won’t be successful or helpful, we’ve already seen much anecdotal evidence of this worldwide & now it’s time for MM Pharmas to put this to the test & gain the evidence needed to have these drugs registered & available legally.  

 
watchlist Created with Sketch. Add RGT (ASX) to my watchlist
(20min delay)
Last
55.0¢
Change
0.015(2.80%)
Mkt cap ! $26.62M
Open High Low Value Volume
50.0¢ 55.0¢ 40.5¢ $9.135K 17.05K

Buyers (Bids)

No. Vol. Price($)
1 679 51.0¢
 

Sellers (Offers)

Price($) Vol. No.
54.0¢ 24 1
View Market Depth
Last trade - 14.16pm 04/10/2024 (20 minute delay) ?
RGT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.